Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse

American Journal of Hematology

Volumn 85, Issue 1, 2010, Pages 41-45

  Solovey, Anna ^a   Kollander, Rahn ^a   Milbauer, Liming Chang ^a   Abdulla, Fuad ^a   Chen, Yingie ^a   Kelm Jr , Robert J ^b   Hebbel, Robert P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; THROMBOPLASTIN; NOS3 PROTEIN, MOUSE;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGY; BLOOD CLOTTING; BREATHING; CONTROLLED STUDY; DIET; DOWN REGULATION; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GENETICS; HBERK1 SICKLE MICE; IN VIVO STUDY; INFLAMMATION; MOUSE; MOUSE STRAIN; NONHUMAN; NY1DD SICKLE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY VEIN; REOXYGENATION; SICKLE CELL ANEMIA; THROMBOSIS; TRANSGENIC MOUSE; ANIMAL; CELL CULTURE; ENDOTHELIUM CELL; METABOLISM; MOUSE MUTANT;

ANEMIA, SICKLE CELL; ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; THROMBOPLASTIN;

EID: 74049088214     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Francis RB Jr, Hebbel RP. Hemostasis. In: Embury SH, Hebbel RP, Steinberg MH, Mohandas N, editors. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press; 1994. pp 299-310.
2. Tomer A, Harker LA, Kasey S, et al. Thrombogenesis in sickle cell disease. J Lab Clin Med 2001;137:398-407.
3. Solovey A, Kollander R, Shet A, et al. Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood 2004;104:840-846.
4. Osarogiabon UR, Choong S, Belcher JD, et al. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 2000;96:314-320.
5. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 2000;106:411-420.
6. Kollander R, Solovey A, Milbauer LC, et al. NFκB component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: Implications for the coagulopathy of sickle cell disease. Translational Res, in press.
7. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy. Microcirculation 2004;11: 129-151.
8. Belcher JD, Bryant CJ, Nguyen J, et al. Transgenic sickle mice have vascular inflammation. Blood 2003;101:3953-3959.
9. Yang Y, Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000;101:2144-2148.
10. Pérez-Ruiz A, Montes R, Velasco F, et al. Regulation by nitric oxide of endotoxin-induced tissue factor and plasminogen activator inhibitor-1 in endothelial cells. Thromb Haemost 2002;88:1060-1065.
11. Ohashi Y, Kawashima S, Hirata K, et al. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 1998;102:2061-2071.
12. Jones SP, Greer JJ, van Haperen R, et al. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci USA 2003;100:4891-4896.
13. Belhassen L, Pelle G, Sediame S, et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stressmediated vasodilation. Blood 2001;97:1584-1589.
14. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8:1383-1389.
15. Prengler M, Pavlakis SG, Prohovnik I, Adams RJ. Sickle cell disease: The neurological complications. Ann Neurol 2002;53:543-552.
16. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997;78: 747-754.
17. Colasanti M, Persichini T. Nitric oxide: An inhibitor of NF-kappaB/Rel system in glial cells. Brain Res Bull 2000;52:155-161.
18. Braam B, de Roos R, Dijk A, et al. Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells. Am J Physiol Heart Circ Physiol 2004;287:H1977-H1986.
19. Zhuravilova E, Barbakadze T, Narmania N, et al. Inhibition of nitric oxide synthase and farnesyltransferase change the activities of several transcription factors. J Mol Neurosci 2007;31:281-287.
20. Lazzerini G, Turco SD, Basta G, et al. Prominent role of NF-kappaB in the induction of endothelial activation by endogenous nitric oxide inhibition. Nitric Oxide, 2009;21:184-91.
21. Minneci PC, Deans KJ, Zhi H, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005;115:3409-3417.
22. Wood KC, Hebbel RP, Lefer DJ, Granger DN. Critical role of endothelial cellderived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction. Free Rad Biol Med 2006;40:1443-1453.
23. Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005;294:81-90.
24. Morris CR, Kuypers FA, Larkin S, et al. Patterns of arginine and nitric oxide in sickle cell disease patients with vaso-oclusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 2000;22:515-520.
25. De Castro LM, Jonassaint JC, Graham FL, et al. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol 2008;83:19-25.
26. Schnog JB, Teerlink T, van der Dijs FP, et al. Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease. Ann Hematol 2005;84:282-286.
27. Hsu L, Champion H, Campbell-Lee S, et al. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007;109:3088-3098.
28. Ravi K, Brennan LA, Levic S, et al. S-Nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc Natl Acad Sci USA 2004;101:2619-2624.
29. Kaul DK, Liu XD, Fabry ME, Nagel RL. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol 2000; 278:H1799-H1806.
30. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003;102: 2678-2683.
31. Dias-da-Motta PM, Arruda VR, Muscara MN, et al. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anemia. Br J Hematol 1996;93:333-340.
32. Aslan M, Ryan TM, Adler B, et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Prod Natl Acad Sci USA 2001;98:15215-15220.
33. Baldus S, Eiserich JP, Brennan ML, et al. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Rad Biol Med 2002;33: 1010.
34. Hebbel RP, Vercellotti GM, Nath KA. A systems biology consideration of the vasculopathy of sickle cell anemia: The need for multi-modality chemo-prophylaxis. Cardiovasc Hematol Disord Drug Targets, 2009 Sept 15 [Epub].
35. Shesely EG, Maeda N, Kim HS, et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996;93: 13176-13181.
36. Voigtlander C, Rand A, Lui S-L, et al. Suppression of tissue factor expression, cofactor activity, and metastatic potential of murine melanoma cells by the Nterminal domain of adenovirus E1A 12S protein. J Cell Biochem 2002;85:54-71.
37. Suda O, Tsutsui M, Morishita T, et al. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice. Circulation 2002;106:1729-1735.